[ad_1]
COVID-19 vaccine in Lithuania. Photo of the Lithuanian Armed Forces
The country’s medical facilities will be vaccinated by a specialized company, Armila, which will take over the activities of the previously successful Sotus Harvest company.
The BNS was informed about this by the Center for Extreme Health Situations (ESSC) on Wednesday. It notes that a contract has been signed with another company to ensure the quality and smooth delivery of the vaccine. This is claimed to have been done after evaluating the circumstances and in accordance with the requirements of the law.
Armila is presented as part of the Walgreens Boots Alliance, one of the largest international pharmaceutical companies in 25 countries. Armila’s main area of activity is the wholesale of pharmaceutical products for pharmacies and hospitals.
According to information provided by Creditinfo, since 1996. The company, which was operating at the end of the year, is owned by the British holding company WBA UK Holdco 1 Limited. 2019 Armila’s revenue exceeded 72 million. Eur, mon has its own pharmaceutical logistics warehouse and employs 91 people.
Vra that contract of 462,000 euros with Sotus Cosecha, which employs two mons, and annual income in 2019 for an amount of 5,026 EUR, was suspended during the week to assess the circumstances in which temperature fluctuations were detected during vaccination.
Last week, a shipment of BioNTech and Pfizer vaccines was suspended in the Kaunas and Panevis regions because the required temperature could not be verified during the transport of the vaccine. The shipment contained nearly 4,700 doses of vaccine.
The saturated crop won the ESSC bid for the vaccine introduction, but the vaccine shipment was transported by subcontractor Mon Radusa.
Rayti komentar
[ad_2]
